These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17957038)

  • 1. Dysregulated pyruvate dehydrogenase complex in Zucker diabetic fatty rats.
    Schummer CM; Werner U; Tennagels N; Schmoll D; Haschke G; Juretschke HP; Patel MS; Gerl M; Kramer W; Herling AW
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E88-96. PubMed ID: 17957038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of the skeletal muscle pyruvate dehydrogenase complex in the Otsuka Long-Evans Tokushima Fatty rat both before and after the onset of diabetes mellitus.
    Bajotto G; Murakami T; Nagasaki M; Tamura T; Tamura N; Harris RA; Shimomura Y; Sato Y
    Life Sci; 2004 Sep; 75(17):2117-30. PubMed ID: 15312755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.
    Sugden MC; Holness MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):151-65. PubMed ID: 12476789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids.
    Bajotto G; Murakami T; Nagasaki M; Qin B; Matsuo Y; Maeda K; Ohashi M; Oshida Y; Sato Y; Shimomura Y
    Metabolism; 2006 Mar; 55(3):317-23. PubMed ID: 16483874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.
    Leonard BL; Watson RN; Loomes KM; Phillips AR; Cooper GJ
    Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats.
    Beha A; Juretschke HP; Kuhlmann J; Neumann-Haefelin C; Belz U; Gerl M; Kramer W; Roden M; Herling AW
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E989-97. PubMed ID: 16380389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.
    Welch MJ; Lewis JS; Kim J; Sharp TL; Dence CS; Gropler RJ; Herrero P
    J Nucl Med; 2006 Apr; 47(4):689-97. PubMed ID: 16595504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary conjugated linoleic acid preserves pancreatic function and reduces inflammatory markers in obese, insulin-resistant rats.
    Noto A; Zahradka P; Ryz NR; Yurkova N; Xie X; Taylor CG
    Metabolism; 2007 Jan; 56(1):142-51. PubMed ID: 17161237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs.
    Sugden MC; Holness MJ
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E855-62. PubMed ID: 12676647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure.
    Goh TT; Mason TM; Gupta N; So A; Lam TK; Lam L; Lewis GF; Mari A; Giacca A
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E549-60. PubMed ID: 17003242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects.
    Majer M; Popov KM; Harris RA; Bogardus C; Prochazka M
    Mol Genet Metab; 1998 Oct; 65(2):181-6. PubMed ID: 9787110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defect in glucokinase translocation in Zucker diabetic fatty rats.
    Fujimoto Y; Donahue EP; Shiota M
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E414-23. PubMed ID: 15138155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of the inhibition of fatty acid oxidation on pyruvate dehydrogenase complex activity in tissues of lean and obese mice.
    Bryson JM; Cooney GJ; Wensley VR; Phuyal JL; Caterson ID
    Int J Obes Relat Metab Disord; 1996 Aug; 20(8):738-44. PubMed ID: 8856397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of the KATP channel subunit, Kir6.2, is associated with decreased expression of neuropeptide Y and agouti-related protein in the hypothalami of Zucker diabetic fatty rats.
    Gyte A; Pritchard LE; Jones HB; Brennand JC; White A
    J Neuroendocrinol; 2007 Dec; 19(12):941-51. PubMed ID: 18001323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal activity of Akt kinase in obese Zucker rats.
    Zdychová J; Kazdová L; Pelikanová T; Lindsley JN; Anderson S; Komers R
    Exp Biol Med (Maywood); 2008 Oct; 233(10):1231-41. PubMed ID: 18641049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction.
    Flamment M; Arvier M; Gallois Y; Simard G; Malthièry Y; Ritz P; Ducluzeau PH
    Biochimie; 2008 Sep; 90(9):1407-13. PubMed ID: 18534199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat--role of food intake and corticosterone.
    Bates HE; Kiraly MA; Yue JT; Goche Montes D; Elliott ME; Riddell MC; Matthews SG; Vranic M
    Metabolism; 2007 Aug; 56(8):1065-75. PubMed ID: 17618951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.